GAP43 and Alzheimer disease: Compared with CN ε4− group, higher CSF GAP-43 levels were observed in MCI ε4+, AD ε4−, and AD ε4+ groups (p = 0.045, p = 0.027, p < 0.001, respectively) (Figure 1B).